SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-15-008440
Filing Date
2015-06-17
Accepted
2015-06-17 20:33:30
Documents
1
Period of Report
2015-06-15

Document Format Files

Seq Description Document Type Size
1 rrd425793.html 4  
1 rrd425793.xml 4 7657
  Complete submission text file 0001181431-15-008440.txt   9033
Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O AVALANCHE BIOTECHNOLOGIES, INC. 1035 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address
Gasmi Mehdi (Reporting) CIK: 0001614875 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 15938452